Aprepitant/Fosaprepitant Dimeglumine and Olaratumab Intravenous
Determining the interaction of Aprepitant/Fosaprepitant Dimeglumine and Olaratumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aprepitant
Brand name: Cinvanti, Emend, Emend 3-Day, Emend 2-Day
Synonyms: Aprepitant
Generic Name: olaratumab
Brand name: Lartruvo
Synonyms: Olaratumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aprepitant/Fosaprepitant Dimeglumine-Oleptro
- Aprepitant/Fosaprepitant Dimeglumine-Oleptro Oral
- Aprepitant/Fosaprepitant Dimeglumine-Olmesartan
- Aprepitant/Fosaprepitant Dimeglumine-Olmesartan and Hydrochlorothiazide
- Aprepitant/Fosaprepitant Dimeglumine-Olmesartan Medoxomil
- Aprepitant/Fosaprepitant Dimeglumine-Olmesartan Medoxomil and Hydrochlorothiazide
- Olaratumab Intravenous-Apresazide
- Olaratumab Intravenous-Apresoline
- Olaratumab Intravenous-Apresoline Injection
- Olaratumab Intravenous-Apri
- Olaratumab Intravenous-Apriso
- Olaratumab Intravenous-Aprizio Pak